黒色腫診断&治療薬の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2489)
◆英語タイトル:Global Melanoma Diagnostics and Therapeutics Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2489
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:109
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、黒色腫診断&治療薬の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(結節型黒色腫、表在性黒色腫、無色素性黒色腫、その他)、用途別市場規模(病院、診断センター、医療機関、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・黒色腫診断&治療薬の市場動向
・企業の競争状況、市場シェア
・黒色腫診断&治療薬の種類別市場規模(結節型黒色腫、表在性黒色腫、無色素性黒色腫、その他)
・黒色腫診断&治療薬の用途別市場規模(病院、診断センター、医療機関、その他)
・黒色腫診断&治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・黒色腫診断&治療薬の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・黒色腫診断&治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・黒色腫診断&治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・黒色腫診断&治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Abbott、Agilent Technologies、AstraZeneca、Bristol-Myers Squibb、Eli Lilly、GlaxoSmithKline、Merck、Novartis、Pfizer、Qiagen、Roche、Sanofi)
・結論
【レポートの概要】

Melanoma is one of the serious types of skin cancer that develops from pigment-containing cells called melanocytes. The market for melanoma diagnostics and therapeutics is increasing at a significant rate due to an increase in the prevalence of melanoma and improvement in healthcare facilities.

Market Analysis and Insights: Global Melanoma Diagnostics and Therapeutics Market
The global Melanoma Diagnostics and Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Melanoma Diagnostics and Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Melanoma Diagnostics and Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Melanoma Diagnostics and Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Melanoma Diagnostics and Therapeutics market.

Global Melanoma Diagnostics and Therapeutics Scope and Market Size
Melanoma Diagnostics and Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Melanoma Diagnostics and Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Nodular Melanoma
Superficial Spreading Melanoma
Amelanotic Melanoma
Others

Segment by Application
Hospital
Diagnostic Center
Medical Institution
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Agilent Technologies
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
GlaxoSmithKline
Merck
Novartis
Pfizer
Qiagen
Roche
Sanofi

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melanoma Diagnostics and Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nodular Melanoma
1.2.3 Superficial Spreading Melanoma
1.2.4 Amelanotic Melanoma
1.2.5 Others
1.3 Market by Application
1.3.1 Global Melanoma Diagnostics and Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Medical Institution
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Melanoma Diagnostics and Therapeutics Market Perspective (2016-2027)
2.2 Melanoma Diagnostics and Therapeutics Growth Trends by Regions
2.2.1 Melanoma Diagnostics and Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Melanoma Diagnostics and Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Melanoma Diagnostics and Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Melanoma Diagnostics and Therapeutics Industry Dynamic
2.3.1 Melanoma Diagnostics and Therapeutics Market Trends
2.3.2 Melanoma Diagnostics and Therapeutics Market Drivers
2.3.3 Melanoma Diagnostics and Therapeutics Market Challenges
2.3.4 Melanoma Diagnostics and Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Melanoma Diagnostics and Therapeutics Players by Revenue
3.1.1 Global Top Melanoma Diagnostics and Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Melanoma Diagnostics and Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Melanoma Diagnostics and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Melanoma Diagnostics and Therapeutics Revenue
3.4 Global Melanoma Diagnostics and Therapeutics Market Concentration Ratio
3.4.1 Global Melanoma Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melanoma Diagnostics and Therapeutics Revenue in 2020
3.5 Melanoma Diagnostics and Therapeutics Key Players Head office and Area Served
3.6 Key Players Melanoma Diagnostics and Therapeutics Product Solution and Service
3.7 Date of Enter into Melanoma Diagnostics and Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Melanoma Diagnostics and Therapeutics Breakdown Data by Type
4.1 Global Melanoma Diagnostics and Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Melanoma Diagnostics and Therapeutics Forecasted Market Size by Type (2022-2027)

5 Melanoma Diagnostics and Therapeutics Breakdown Data by Application
5.1 Global Melanoma Diagnostics and Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Melanoma Diagnostics and Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Melanoma Diagnostics and Therapeutics Market Size (2016-2027)
6.2 North America Melanoma Diagnostics and Therapeutics Market Size by Type
6.2.1 North America Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Melanoma Diagnostics and Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2027)
6.3 North America Melanoma Diagnostics and Therapeutics Market Size by Application
6.3.1 North America Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Melanoma Diagnostics and Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2027)
6.4 North America Melanoma Diagnostics and Therapeutics Market Size by Country
6.4.1 North America Melanoma Diagnostics and Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Melanoma Diagnostics and Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Melanoma Diagnostics and Therapeutics Market Size (2016-2027)
7.2 Europe Melanoma Diagnostics and Therapeutics Market Size by Type
7.2.1 Europe Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Melanoma Diagnostics and Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2027)
7.3 Europe Melanoma Diagnostics and Therapeutics Market Size by Application
7.3.1 Europe Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Melanoma Diagnostics and Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2027)
7.4 Europe Melanoma Diagnostics and Therapeutics Market Size by Country
7.4.1 Europe Melanoma Diagnostics and Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Melanoma Diagnostics and Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Type
8.2.1 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Application
8.3.1 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Region
8.4.1 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Melanoma Diagnostics and Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Melanoma Diagnostics and Therapeutics Market Size (2016-2027)
9.2 Latin America Melanoma Diagnostics and Therapeutics Market Size by Type
9.2.1 Latin America Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Melanoma Diagnostics and Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Melanoma Diagnostics and Therapeutics Market Size by Application
9.3.1 Latin America Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Melanoma Diagnostics and Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Melanoma Diagnostics and Therapeutics Market Size by Country
9.4.1 Latin America Melanoma Diagnostics and Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Melanoma Diagnostics and Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Type
10.2.1 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Application
10.3.1 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Country
10.4.1 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Melanoma Diagnostics and Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Melanoma Diagnostics and Therapeutics Introduction
11.1.4 Abbott Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Melanoma Diagnostics and Therapeutics Introduction
11.2.4 Agilent Technologies Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.2.5 Agilent Technologies Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Melanoma Diagnostics and Therapeutics Introduction
11.3.4 AstraZeneca Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Melanoma Diagnostics and Therapeutics Introduction
11.4.4 Bristol-Myers Squibb Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Melanoma Diagnostics and Therapeutics Introduction
11.5.4 Eli Lilly Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.5.5 Eli Lilly Recent Development
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Company Details
11.6.2 GlaxoSmithKline Business Overview
11.6.3 GlaxoSmithKline Melanoma Diagnostics and Therapeutics Introduction
11.6.4 GlaxoSmithKline Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.6.5 GlaxoSmithKline Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Melanoma Diagnostics and Therapeutics Introduction
11.7.4 Merck Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Melanoma Diagnostics and Therapeutics Introduction
11.8.4 Novartis Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Melanoma Diagnostics and Therapeutics Introduction
11.9.4 Pfizer Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.9.5 Pfizer Recent Development
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Melanoma Diagnostics and Therapeutics Introduction
11.10.4 Qiagen Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.10.5 Qiagen Recent Development
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Melanoma Diagnostics and Therapeutics Introduction
11.11.4 Roche Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.11.5 Roche Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Melanoma Diagnostics and Therapeutics Introduction
11.12.4 Sanofi Revenue in Melanoma Diagnostics and Therapeutics Business (2016-2021)
11.12.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 黒色腫診断&治療薬の世界市場規模・現状・予測2021年-2027年(Global Melanoma Diagnostics and Therapeutics Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。